10.35Open10.35Pre Close0 Volume0 Open Interest71.00Strike Price0.00Turnover2552.19%IV5.39%PremiumDec 13, 2024Expiry Date6.19Intrinsic Value100Multiplier0DDays to Expiry4.16Extrinsic Value100Contract SizeAmericanOptions Type0.9630Delta0.0221Gamma12.35Leverage Ratio-110.8823Theta0.0000Rho11.89Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet